CIGNA is an American insurance company that is specialized in various types of health insurance, in particular with corporate customers.
P/E ratio for Cigna (CI)
P/E ratio as of April 2023 (TTM): 11.8
According to Cigna's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 11.8473. At the end of 2021 the company had a P/E ratio of 14.5.
P/E ratio history for Cigna from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 14.5 | 65.1% |
| 2020 | 8.81 | -41.08% |
| 2019 | 14.9 | -14.64% |
| 2018 | 17.5 | -20.95% |
| 2017 | 22.1 | 21.38% |
| 2016 | 18.2 | 1.52% |
| 2015 | 18.0 | 37.28% |
| 2014 | 13.1 | -20.18% |
| 2013 | 16.4 | 69.51% |
| 2012 | 9.68 | 12.9% |
| 2011 | 8.57 | 16.57% |
| 2010 | 7.35 | -2.49% |
| 2009 | 7.54 | -51.53% |
| 2008 | 15.6 | 13.17% |
| 2007 | 13.7 | 9.28% |
| 2006 | 12.6 | 43.69% |
| 2005 | 8.75 | 13.7% |
| 2004 | 7.70 | -35.42% |
| 2003 | 11.9 | -181.94% |
| 2002 | -14.6 | -205.69% |
| 2001 | 13.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Centene CNC | 30.3 | 156.00% | 🇺🇸 USA |
 Humana HUM | 21.9 | 84.63% | 🇺🇸 USA |
 UnitedHealth UNH | 22.0 | 85.47% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.